wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30471456-291D1860-DF42-489E-AFF1-8257CC60F012
Q30471456-291D1860-DF42-489E-AFF1-8257CC60F012
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30471456-291D1860-DF42-489E-AFF1-8257CC60F012
Normalization of the vasculature for treatment of cancer and other diseases.
P2860
Q30471456-291D1860-DF42-489E-AFF1-8257CC60F012
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30471456-291D1860-DF42-489E-AFF1-8257CC60F012
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d3519f3a09942dc437705dc25a4568a5b104d0c8
P2860
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma